Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) has shared an update.
Innovative Pharmaceutical Biotech Limited has announced a special general meeting to be held on March 28, 2025, to appoint SFAI (HK) CPA Limited as the company’s auditor. This move is expected to streamline the company’s financial auditing processes, potentially enhancing its operational efficiency and transparency, which could positively impact its market positioning and stakeholder confidence.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical products and therapies.
YTD Price Performance: -14.76%
Average Trading Volume: 987,899
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$326.2M
See more insights into 0399 stock on TipRanks’ Stock Analysis page.